Introduction: With increasing availability of pathogen genetic and especially whole-genome sequence data, there is a pressing need for analytical tools and innovative approaches to make use of them. In particular, methods for using genomic data to make inferences about transmission chains and pathogen evolution under selection by host immunity, vaccines, and antibiotics, are still in their infancy. These questions are fundamentally different from the types of questions asked when examining one sequence at a time, which illuminate the biology of conserved aspects of infection and pathogenesis. Population genomic studies shed light on population heterogeneity in the pathogen, its consequences and causes. These inferences naturally lend themselves to the estimation of parameters for transmission-dynamic models and, even more fundamentally, to the determination of how such models should be structured, and the testing of their predictions. To date, using MIDAS and non-MIDAS funding for analytic efforts, and non-MIDAS funding for the costs of sequencing, we have made a number of significant discoveries over the last five years using pathogen population genomics and genetics, and we have identified many opportunities to improve and expand methods over the next five years, as well as to apply existing methods to significant questions of biology and epidemiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54GM088558-06
Application #
8796407
Study Section
Special Emphasis Panel (ZGM1-BBCB-5 (MI))
Project Start
Project End
Budget Start
2014-09-20
Budget End
2015-08-31
Support Year
6
Fiscal Year
2014
Total Cost
$66,108
Indirect Cost
$25,174
Name
Harvard University
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Cobey, Sarah; Baskerville, Edward B; Colijn, Caroline et al. (2017) Host population structure and treatment frequency maintain balancing selection on drug resistance. J R Soc Interface 14:
Eyal, Nir; Lipsitch, Marc (2017) Vaccine testing for emerging infections: the case for individual randomisation. J Med Ethics 43:625-631
Feng, Shuo; Fowlkes, Ashley L; Steffens, Andrea et al. (2017) Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness. Epidemiology 28:514-524
Buckee, Caroline O; Tatem, Andrew J; Metcalf, C Jessica E (2017) Seasonal Population Movements and the Surveillance and Control of Infectious Diseases. Trends Parasitol 33:10-20
Wesolowski, Amy; Zu Erbach-Schoenberg, Elisabeth; Tatem, Andrew J et al. (2017) Multinational patterns of seasonal asymmetry in human movement influence infectious disease dynamics. Nat Commun 8:2069
Halloran, M Elizabeth; Auranen, Kari; Baird, Sarah et al. (2017) Simulations for designing and interpreting intervention trials in infectious diseases. BMC Med 15:223
Worby, Colin J; Wallinga, Jacco; Lipsitch, Marc et al. (2017) Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component. Epidemics 19:74-82
Kraemer, Moritz U G; Faria, Nuno R; Reiner Jr, Robert C et al. (2017) Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study. Lancet Infect Dis 17:330-338
Nathavitharana, Ruvandhi R; Shi, Cynthia X; Chindelevitch, Leonid et al. (2017) Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru. Emerg Infect Dis 23:1887-1890
Andam, Cheryl P; Worby, Colin J; Gierke, Ryan et al. (2017) Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States. Emerg Infect Dis 23:1012-1015

Showing the most recent 10 out of 405 publications